Response to "Epidemiology of neuromyelitis optica spectrum disorder''.

Dale, G H; Bacher Svendsen, K; Gjelstrup, M C; Christensen, T; Houen, G; Nielsen, E; Bek, T; Petersen, T

Dale, G H; Bacher Svendsen, K; Gjelstrup, M C; Christensen, T; Houen, G; Nielsen, E; Bek, T; Petersen, T.

Afiliación

Dale GH; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Bacher Svendsen K; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Gjelstrup MC; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Christensen T; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Houen G; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Nielsen E; Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark.
Bek T; Department of Neuroradiology, Aarhus University Hospital, Aarhus, Denmark.
Petersen T; Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.

Acta Neurol Scand ; 137(6): 628-629, 2018 06.

Article en En | MEDLINE | ID: mdl-29732541

Asunto(s)

Neuromielitis Óptica; Acuaporina 4; Dinamarca; Humanos; Incidencia

Palabras clave

demyelinating diseases; immunology; neuroepidemiology; neuroimaging

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuromielitis Óptica Tipo de estudio: Incidence_studies / Prognostic_studies / Screening_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Acta Neurol Scand Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Dinamarca

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google